Concepedia

James C. Hallman

JC

Statistics

Publications

2

Citations

193

H-Index

2

Active since

1993

Affiliations

St. Jude Children's Research Hospital(Current)

James C. Hallman is an author at St. Jude Children's Research Hospital specializing in pharmacodynamics of anticancer agents, cancer pharmacology, and oncology.

Publications per year

1993–1994

2

Publications

2

Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin.

Peter J. Houghton, Pamela J. Cheshire, James C. Hallman et al. · PubMed · 1993 · 161 citations

, , +15

Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancers

Peter J. Houghton, Pamela J. Cheshire, James C. Hallman et al. · Cancer Chemotherapy and Pharmacology · 1994 · 32 citations

, , +8

1–2 of 2